MERIDIAN, Miss., Dec. 26, 2016 -- Many people believe dry eye is a normal part of aging or life and just has to be endured. However, relief is available. Xiidra™ prescription eye drops are one of the most effective treatments for dry eye. Primary Eyecare and Optical of Meridian is pleased to announce that they will now be offering Xiidra™ prescription eye drops for the treatment of the common condition of dry eye.
It is estimated that over 30 million people in the U.S. suffer from dry eye, but less than one million receive appropriate treatment for it. Dry eye affects ten times the number of people afflicted with glaucoma, another common eye condition.
The condition of dry eye is more common in older individuals. It is characterized by a lack of tears produced in the eyes. In some cases, tear production is adequate, but the quality of the tears is low. In these cases, tears lack a proper amount of essential oils and mucus, causing the water portion of the tears to evaporate too quickly.
The symptoms of dry eye include a lack of moisture in the eyes, a gritty feeling, a scratching sensation when opening and closing the eyes, itchiness, and general eye discomfort. As the condition persists and progresses, injury to the eye can result. In some cases, these injuries can cause scar tissue and lead to permanent vision issues and eye damage. Fortunately, Xiidra can help persons who are experiencing these symptoms to have better eye health and a higher degree of comfort.
Xiidra has been thoroughly tested and approved by the FDA. These prescription eye drops can help to bring significant improvement in both the symptoms and physical signs of dry eye. Both eye dryness and the markers that indicate corneal straining in the eye are markedly reduced when Xiidra is used, and these results have been substantiated in clinical studies. Patients with dry eye who use Xiidra eye drops commonly show significant improvements in their eye health within two weeks.
Meridian optometrist Dr. Minh Duong says, “Xiidra prescription eye drops do far more than over the counter eye drops, as OTC products do not address the underlying issues of dry eye, including inflammation. Here at Primary Eyecare and Optical of Meridian, we are pleased to offer this safe, effective product to our clients with dry eye.”
Primary Eyecare and Optical of Meridian is served by Dr. Minh Duong, OD and Dr. Jennifer Dooley, OD. They are located at 4721 26th Avenue in Meridian, Mississippi. Those in the public who would like to learn more about the Xiidra treatment for dry eye or book an appointment may do so by calling (601) 485-2020. Additional information about the practice is also available on their website at http://www.primaryeyecarems.com/.
Primary Eyecare and Optical of Meridian, (601) 485-2020


Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 



